Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6823524 | 0.89 | FDPS (0.42) | DGAT1LMNAFDPS | |
| SCHEMBL8835291 | 0.81 | DGAT1 (0.34) | DGAT1 | |
| SCHEMBL337595 | 0.78 | MMP1 (0.34) | DGAT1FDPS | |
| SCHEMBL18759662 | 0.77 | CYP4F2 (0.40) | LMNA | |
| SCHEMBL9578846 | 0.77 | FDPS (0.32) | FDPS | |
| SCHEMBL16048 | 0.77 | CYP4F2 (0.40) | LMNA | |
| SCHEMBL413276 | 0.75 | CYP4F2 (0.39) | LMNA | |
| SCHEMBL19278938 | 0.75 | CYP4F2 (0.39) | LMNA | |
| SCHEMBL11529906 | 0.73 | PTPN1 (0.41) | LMNAFDPS | |
| SCHEMBL3740634 | 0.73 | FDPS (0.30) | FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 682 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120119112-A | Method for recovering aluminum matrix from aluminum target containing indium-tin solder | 新疆众和股份有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-117800858-B | Preparation method for catalytic cyanation of milbelin | 南京津泓科技有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-117800858-A | Preparation method for catalytic cyanation of milbelin | 南京津泓科技有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-114085176-A | Synthesis method of 5-Boc-5-azaspiro [2.3] hexane-1-carboxylic acid | 吉尔生化（上海）有限公司 | 2022-02-25 | — | — | CN | claimed |
| US-20220025424-A1 | COMPOSITIONS AND METHODS FOR PRODUCING STEREOISOMERICALLY PURE AMINOCYCLOPROPANES | IMAGO BIOSCIENCES, INC. | 2022-01-27 | — | — | US | claimed |
| CN-111116594-A | C-6 modified NanoLuc analogue and preparation method and application thereof | 山东大学 | 2020-05-08 | — | — | CN | claimed |
| CN-111072669-A | Phenyl imidazopyrazinone compound and preparation method and application thereof | 山东大学 | 2020-04-28 | — | — | CN | claimed |
| WO-2018035249-A1 | COMPOSITIONS AND METHODS FOR PRODUCING STEREOISOMERICALLY PURE AMINOCYCLOPROPANES | IMAGO BIOSCIENCES, INC. (US) | 2018-02-22 | — | — | WO | claimed |
| CN-103789055-B | M15 methanol gasoline vapor pressure stabilizer | GANSU SANGTIAN CLEAN ENERGY DEV CO LTD | 2015-06-17 | — | — | CN | claimed |
| US-7265229-B2 | Method for synthesizing macrosphelides | LEAD CHEMICAL CO., LTD. (JP) | 2007-09-04 | — | — | US | claimed |
| US-20060030720-A1 | Method for synthesizing macrosphelides | LEAD CHEMICAL CO., LTD. (JP) | 2006-02-09 | — | — | US | claimed |
| JP-57200396-A | — | — | None | — | — | JP | disclosed |
| CN-122028917-A | Compositions and methods for treating and preventing bacterial infections caused by gram positive bacteria | 莱托克斯有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-4734985-A1 | PREVENTION, INHIBITION OR TREATMENT OF CONDITIONS OR DISORDERS MEDIATED BY UROCANATE REDUCTASE | IMPLEXION PHARMA AB (SE) | 2026-05-06 | — | — | EP | disclosed |
| US-12617762-B2 | Carboxy derivatives with antiinflamatory properties | SITRYX THERAPEUTICS LIMITED (GB) | 2026-05-05 | — | — | US | disclosed |
| US-5086065-A | Leukotriene antagonists | ONO PHARMACEUTICAL CO., LTD. (JP) | 1992-02-04 | — | — | US | disclosed |
| EP-0405116-A2 | Phenylalkan(en)oic acids | ONO PHARMACEUTICAL CO., LTD. (JP) | 1991-01-02 | — | — | EP | disclosed |
| JP-S57200396-A | PREPARATION OF ALPHA-AMINOPHOSPHONOACETATES | KYOWA HAKKO KOGYO CO LTD | 1982-12-08 | — | — | JP | disclosed |
| US-4130659-A | Polyprenyl carboxylic acid compound and hypotensive agent containing it as active ingredient | EISAI CO., LTD. (JP) | 1978-12-19 | — | — | US | disclosed |
| US-4107193-A | HYPOTENSIVE | EISAI CO., LTD. (JP) | 1978-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060030720-A1 | Method for synthesizing macrosphelides | ADH1C, HPD, HSD17B12 | DGAT1 43/4885LMNA 1541/4885FDPS 234/4885 |
| US-12617762-B2 | Carboxy derivatives with antiinflamatory properties | CCR1, CBR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | DGAT1 1010/4885LMNA 1950/4885FDPS 3353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.